PL3389653T3 - 2-iminobiotyna do zastosowania w leczeniu uszkodzeń komórek mózgowych - Google Patents

2-iminobiotyna do zastosowania w leczeniu uszkodzeń komórek mózgowych

Info

Publication number
PL3389653T3
PL3389653T3 PL16825913.3T PL16825913T PL3389653T3 PL 3389653 T3 PL3389653 T3 PL 3389653T3 PL 16825913 T PL16825913 T PL 16825913T PL 3389653 T3 PL3389653 T3 PL 3389653T3
Authority
PL
Poland
Prior art keywords
iminobiotin
treatment
brain cell
cell injury
injury
Prior art date
Application number
PL16825913.3T
Other languages
English (en)
Inventor
Paul Willem Theresia Josef Leufkens
Cacha Marie Pétronelle Cathérine Dorothée PEETERS
Huibert Alexander TJABBES
Original Assignee
Neurophyxia B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurophyxia B.V. filed Critical Neurophyxia B.V.
Publication of PL3389653T3 publication Critical patent/PL3389653T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL16825913.3T 2015-12-16 2016-12-16 2-iminobiotyna do zastosowania w leczeniu uszkodzeń komórek mózgowych PL3389653T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15200492 2015-12-16
PCT/NL2016/050880 WO2017105237A1 (en) 2015-12-16 2016-12-16 2-iminobiotin for use in the treatment of brain cell injury

Publications (1)

Publication Number Publication Date
PL3389653T3 true PL3389653T3 (pl) 2024-02-26

Family

ID=54936830

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16825913.3T PL3389653T3 (pl) 2015-12-16 2016-12-16 2-iminobiotyna do zastosowania w leczeniu uszkodzeń komórek mózgowych

Country Status (11)

Country Link
US (3) US10525039B2 (pl)
EP (1) EP3389653B1 (pl)
JP (1) JP6975165B2 (pl)
AU (1) AU2016372396B2 (pl)
CA (1) CA3008790A1 (pl)
DK (1) DK3389653T3 (pl)
ES (1) ES2965754T3 (pl)
FI (1) FI3389653T3 (pl)
PL (1) PL3389653T3 (pl)
PT (1) PT3389653T (pl)
WO (1) WO2017105237A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3389653T3 (pl) 2015-12-16 2024-02-26 Neurophyxia B.V. 2-iminobiotyna do zastosowania w leczeniu uszkodzeń komórek mózgowych
EP3749091A4 (en) * 2018-02-09 2022-01-12 Yale University Methods, systems and compositions for normothermic ex vivo restoration and preservation of intact organs
WO2022203504A1 (en) * 2021-03-23 2022-09-29 Neurophyxia B.V. 2-iminobiotin for use in the treatment of stroke
WO2022203505A1 (en) * 2021-03-23 2022-09-29 Neurophyxia B.V. 2-iminobiotin for use in the treatment of stroke

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200100382A (et) 1999-01-21 2002-12-16 Bristol-Myers Squibb Company Ras-farnesüültransferaasi inhibiitori ja sulfobutüüleeter-7-ß-tsüklodekstriini või 2-hüdroksüpropüül-ß-tsüklodekstriini kompleks ja selle valmistamise meetod
US7087633B2 (en) * 2000-03-31 2006-08-08 Universitair Medisch Centrum Method for treating perinatal asphyxia in a human or animal neonate
NZ524345A (en) 2000-03-31 2004-06-25 Uni Medisch Ct Composition for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth
US7319090B2 (en) 2002-11-27 2008-01-15 University Of North Carolina At Chapel Hill Methods of treating cerebral ischemia
RU2009116455A (ru) 2006-10-04 2010-11-10 Ньюроки А/С (Dk) Применение индуцирующих гипотермию лекарственных средств для лечения ишемии
NZ604498A (en) 2010-05-26 2014-10-31 Neurophyxia B V 2-iminobiotin formulations and uses thereof
SG11201407326XA (en) * 2012-05-23 2014-12-30 Cellix Bio Private Ltd Compositions and methods for treatment of mucositis
GB2504263B (en) * 2012-06-08 2015-09-16 Gw Pharma Ltd Synergistic therapies for neuroprotection
US10092591B2 (en) * 2014-02-27 2018-10-09 University Of Alaska Fairbanks Methods and compositions for the treatment of ischemic injury to tissue using therapeutic hypothermia
PL3389653T3 (pl) * 2015-12-16 2024-02-26 Neurophyxia B.V. 2-iminobiotyna do zastosowania w leczeniu uszkodzeń komórek mózgowych

Also Published As

Publication number Publication date
AU2016372396B2 (en) 2022-04-14
ES2965754T3 (es) 2024-04-16
JP6975165B2 (ja) 2021-12-01
DK3389653T3 (da) 2024-01-02
US20200338046A1 (en) 2020-10-29
EP3389653A1 (en) 2018-10-24
CA3008790A1 (en) 2017-06-22
PT3389653T (pt) 2023-12-28
US20190262316A1 (en) 2019-08-29
US11426387B2 (en) 2022-08-30
EP3389653B1 (en) 2023-11-08
US10525039B2 (en) 2020-01-07
US20200147049A1 (en) 2020-05-14
AU2016372396A1 (en) 2018-06-28
US10722496B2 (en) 2020-07-28
WO2017105237A1 (en) 2017-06-22
FI3389653T3 (fi) 2023-12-18
JP2019501969A (ja) 2019-01-24

Similar Documents

Publication Publication Date Title
ZA201705673B (en) Methods for treating skin
PT3334422T (pt) Utilização de ácido canabidiólico no tratamento de epilepsia
GB201510664D0 (en) Use of cannabinoids in the treatment of epilepsy
GB201614522D0 (en) Use of cannabinoids in the treatment of multiple myeloma
AU364343S (en) Skin toning device
SG10202007559PA (en) Skin treatment apparatus
GB201403104D0 (en) Skin treatment device
IL254142B (en) Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent
PL3215219T3 (pl) System do zabiegów na skórze
PL3277280T3 (pl) Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych
SG11201704499WA (en) Agent for hair deforming treatment
IL251904A0 (en) Epilimod for use in the treatment of melanoma
SG11201704497PA (en) Agent for hair deforming treatment
PT3160464T (pt) 6-hidroxibuspirona para uso no tratamento de transtornos do movimento
IL276577A (en) Methods for treating cardiac injury
SG11201704504PA (en) Agent for hair deforming treatment
IL246855A0 (en) Materials for use in the treatment of retinitis
PT3389653T (pt) 2-iminobiotina para utilização no tratamento de lesão celular cerebral
SG11201704493UA (en) Agent for hair deforming treatment
GB2553527B (en) Headgear suitable for use in hydrotherapy
SMT202200221T1 (it) Medicinale per l'uso nel trattamento della gotta
GB201604658D0 (en) Treatment for pain
PL3291691T3 (pl) Wykorzystanie azotanów w leczeniu poporodowej dysgalakcji u ssaków jednożołądkowych
IL264600B (en) A knife for use in medical treatment
SG11201803077UA (en) Cell treatment apparatus